Positive Airway Pressure Devices Market, Analysis and Forecast, 2021-2030 | by BIS Research

A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea. The system may include a dedicated flow generator and a patient interface.

Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway. Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide. The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.

Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices. These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.

Positive Airway Pressure Devices Market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.

Global Positive Airway Pressure Devices Market Drivers

Currently, the market is mainly being driven by the growing prevalence of obstructive sleep apnea and chronic respiratory diseases. Some countries have registered increasing awareness of the benefits of positive airway pressure (PAP) therapy, and as a result, there has been a hike in the prevalence of PAP therapy in those countries in the past few years.

There has been a steady growth in the number of health-tech startups in the industry. The market entry of new players has been further accelerated by the COVID-19 pandemic. MedTech startups have been responding to the growing demand for ventilators by offering non-invasive unconventional systems and indigenous ventilators. Apart from that, globally, the prevalence of obstructive sleep apnea is expected to exceed 986 million cases by the end of 2026. According to data obtained from the Global Data Health Exchange and BIS Research analysis, the incidence of the condition in North America was as high as 1 in 11 individuals in 2020. The life expectancy in most countries has surged tremendously. The improvement in life expectancy is due to significant advancements in diagnostic technology and medical science. Furthermore, growing awareness regarding health, nutrition, and hygiene has also resulted in increased life expectancy.

The prevalence of diseases among the growing geriatric population has grown at a significant pace during 2015-2019 as compared to those aged 54 and below.

Request Free Sample - Click Here

Positive Airway Pressure Devices Market Challenges

The primary challenge is the lack of awareness of the benefits of positive airway pressure therapy among individuals. Sleep apnea itself faces a significant challenge in getting diagnosed with many individuals unaware that they suffer from the condition. A key restraining factor to the growth in the adoption of PAP devices is their high cost. Additionally, the lack of reimbursement policies by the government and commercial payors also hampers the adoption of PAP devices in emerging economies. These devices are also uncomfortable for many users, which results in the discontinuation of therapy. The global positive airway pressure devices market is also expected to be restrained due to non-adherence.

Positive Airway Pressure Devices Market Opportunities

Owing to the rising focus on remote patient monitoring, mobile health applications, and integration of telemedicine in treatment and diagnostic aspects of healthcare, the development of smart PAP devices offers a novel opportunity to both established and emerging players.

Established PAP device manufacturers can develop devices integrated with a mobile application that would enable patients to monitor their breathing quality, sleep quality, and therapy adherence. Moreover, the mobile application could further facilitate data sharing with a physician for patient monitoring. For instance, Koninklijke Philips N.V. developed DreamMapper, a mobile application compatible with its CPAP devices. The mobile application offers various features such as therapy hours, educational information, progress monitoring, and data sharing with physicians.

Impact of COVID-19 on the Positive Airway Pressure Devices Industry

The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.

The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.

Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.

Bis Research - Emerging Technology Market Research